NEUROLOGICAL CANCER

Clinical trials for NEUROLOGICAL CANCER explained in plain language.

Never miss a new study

Get alerted when new NEUROLOGICAL CANCER trials appear

Sign up with your email to follow new studies for NEUROLOGICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Early trial tests new drug combo for aggressive brain cancers

Disease control Recruiting now

This early-stage study is testing the safety and highest tolerable dose of a two-drug combination called ASTX727 for adults with recurrent IDH-mutant brain tumors that have started growing again. The trial will enroll 18 participants to determine how much medication can be given …

Matched conditions: NEUROLOGICAL CANCER

Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

NEUROLOGICAL CANCER

Get alerted when new NEUROLOGICAL CANCER trials appear

Early trial tests new drug combo for aggressive brain cancers